Jinxin Fertility Group Limited (HKG:1951)

Market Cap	9.21B
Revenue (ttm)	2.99B
Net Income (ttm)	301.27M
Shares Out	2.76B
EPS (ttm)	0.11
PE Ratio	31.39
Forward PE	19.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	140,446,888
Average Volume	119,129,607
Open	3.350
Previous Close	3.330
Day's Range	3.260 - 3.450
52-Week Range	2.070 - 4.640
Beta	1.41
RSI	65.63
Earnings Date	Aug 29, 2025

About Exscientia

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. The company also provides related services, such as nutrition guidance, Chinese medicine treatment, and psycholo...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1951
• Employees: 3,198
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1951

Financial Performance

In 2024, Jinxin Fertility Group's revenue was 2.81 billion, an increase of 0.81% compared to the previous year's 2.79 billion. Earnings were 283.10 million, a decrease of -17.88%.

Financial numbers in EUR